$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Flexor tendons in the hand work in concert with the flexor muscles of the forearm and digital sheaths to enable flexion of the digits and grasping function of the hand. Flexor tendons run along the palmar aspect of the hand; this relatively superficial location often results in injuries to the flexor tendons during trauma to the hand. Tendons heal through a scar tissue response rather than regeneration of normal tendon tissue 1. While this scar tissue provides continuity to the tendon, function is dramatically decreased relative to healthy tendon. Tendon-scar tissue composites are characterized by impaired mechanical properties 1, rendering the repaired tendons more likely to rupture. In addition, scar tissue lacks the organization of the native tendon collagen fiber structure, resulting in an increase in tendon size and bulk. Given the anatomic constraints of the tendon-sheath unit, even a modest increase in tendon size can drastically reduce the gliding function of the tendon, and therefore digit range of motion and hand function.
Prior to the 1960's injuries to the flexor tendons, particularly those in Zone II of the hand, were not routinely repaired due to the severe complications in healing that arose with these repairs 2. This area of the hand was referred to as 'no man's land' 3. However, improvements in surgical techniques, suture patterns and physical therapy rehabilitation protocols have dramatically improved outcomes of flexor tendon repairs 2. Despite these advances, up to 40% of repairs result in sufficient adhesion formation to impede hand function 4. Therefore, a biological approach is required to improve healing. Unfortunately, very little is known about the tendon healing process at the cellular and molecular level. Thus, the goal was to develop a murine model that could be used to improve the fundamental understanding of the cellular and molecular components of flexor tendon healing and the scar formation response, as a means to identify novel therapeutic targets to improve healing.
Larger animal models have been instrumental in furthering understanding of the flexor tendon healing process. Canine and rabbit studies have demonstrated both the intrinsic and extrinsic healing ability of flexor tendons 5,6, the importance of early controlled passive motion in minimizing adhesion formation relative to immobilization 7, as well as the effects of different suture patterns on the healing process 8,9. In addition, the canine model has been useful in testing translational tissue-engineering approaches to improve healing 10. However, there are several important advantages in using a murine model relative to a large animal model, including the relative cost, availability of murine specific reagents, and the ease of generating global knock-outs or tissue-specific deletion/overexpression constructs. Moreover, the functional similarities between human and mice with respect to flexor tendons 11 indicate the potential utility in developing a murine model.
Development of a murine model of flexor tendon transection and repair mimics many aspects of clinical healing, including the formation of abundant scar tissue and impaired mechanical properties. The model described here is not a true recapitulation of clinical practice due to transection of the FDL at the myotendinous junction in order to protect the repair site. Furthermore, this model does not account for the contribution of synovial sheath cells to the healing response, as there is no synovial sheath covering the mid-portion of the tendon where the repair occurs. Despite these limitations, this model has the advantage of generating range of motion-limiting adhesions, which has yet to be demonstrated in murine models that more closely approximate the clinical scenario. This model has been used to assess knock-out mouse models 12,13, and to test different pharmacological approaches to improve healing 14-17. Histological analyses of this model, using immunohistochemistry and in situ hybridization, can provide important insights in to the localization of key genes and proteins during healing. However, histology provides only a cross-sectional spatial analysis and does not permit quantification throughout the entire tissue. Flow cytometry represents a more quantitative approach, but only a very limited number of cells can be isolated from the healing tendon tissue in the mouse model, and this number is further decreased during fixation, permeabilization, and washing steps. Taking this in to account, flow cytometry becomes an unfeasible approach due to the number of animals that would be required. An alternative method is necessary to preserve the majority of this small cell population in order to further characterize the healing milieu. The method used to accomplish this, shown here, involves concentration of the isolated cells via cytology centrifugation onto a glass slide, followed by immunocytochemistry. In the present study EdU (5-ethynyl-2'deoxyuridine, a thymidine analog) incorporation and subsequent labeling was used to determine the relative proliferative state of cells at the healing site. This approach can be applied to test the efficacy of pharmacological treatments on cell proliferation, gene knock-out or overexpression, or to identify and quantify different cell populations.